Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference
Satellos (NASDAQ: MSLE) will present at the Bloom Burton & Co. Healthcare Investor Conference on April 21, 2026, in Toronto.
Rhea-AI Summary
Satellos (NASDAQ: MSLE) will present at the Bloom Burton & Co. Healthcare Investor Conference on April 21, 2026, in Toronto. CEO Frank Gleeson will present on April 21 at 11:30 a.m. ET and CEO Gleeson and CFO Liz Williams will hold one-on-one meetings April 21-22.
The live presentation will be available via webcast on the company’s Events and Presentations page, with a replay accessible after the session.
Positive
- None.
Negative
- None.
Details
News Market Reaction – MSLE
On Apr 9, the day this news came out, MSLE closed 0.80% below the previous close.
Data tracked by StockTitan Argus for the Apr 9 session.
Key Figures
- Conference dates
- April 21–22, 2026
- Bloom Burton & Co. Healthcare Investor Conference
- Presentation date
- April 21, 2026
- Satellos CEO conference presentation
- Presentation time
- 11:30 a.m. ET
- Bloom Burton conference presentation slot
Historical Context
-
2025 results, US$57.2M financing, Nasdaq listing, Phase 2 initiations.
-
Interim SAT-3247 clinical and biomarker data in DMD and FSHD models.
-
Planned oral and poster presentations at 2026 MDA conference.
-
Virtual KOL event on DMD and SAT-3247 program details.
-
Participation in multiple investor conferences with webcasts and meetings.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TORONTO, April 09, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“ Satellos ” or the “ Company ”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that it will participate in the Bloom Burton & Co. Healthcare Investor Conference taking place April 21-22, 2026, at the Metro Toronto Convention Centre in Toronto, Canada.
Satellos Co-founder and CEO Frank Gleeson will provide a presentation on April 21 and along with Liz Williams, Chief Financial Officer, will participate in one-on-one meetings during the conference.
2026 Bloom Burton & Co. Healthcare Investor Conference
Format: Presentation and webcast
Presenter: Frank Gleeson, President and CEO
Date: Tuesday, April 21
Time: 11:30 a.m. ET
Location: Metro Toronto Convention Centre
The presentation will be available via live webcast on the Events and Presentations page in the Investors section of the Company’s website, and a replay will be available following the presentation.
ABOUT SATELLOS BIOSCIENCE INC.
Satellos is a clinical-stage drug development company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases. Through its research, Satellos has developed SAT-3247, a first-of-its-kind, orally administered small molecule therapy designed to address deficits in muscle repair and regeneration. SAT-3247 is being evaluated as a potential disease-modifying treatment, initially for DMD, in two Phase II clinical trials: BASECAMP in pediatrics and TRAILHEAD in adults. SAT-3247 targets AAK1, a key protein that Satellos has identified as capable of helping restore the body’s natural muscle repair and regeneration biology, a fundamental stem cell driven process that is disrupted in DMD and other degenerative conditions. By addressing the loss in a dystrophin-independent manner, SAT-3247 may re-establish the biochemical signals needed to support muscle regeneration, with potential broad applicability as either a stand-alone or adjunctive therapy. Satellos has identified additional muscle diseases and injury conditions where restoring muscle repair and regeneration may have therapeutic benefit and plans to pursue these opportunities in future clinical development. For more information, visit www.satellos.com.
CONTACTS
Investors: Dan Ferry, LifeSci Advisors, daniel@lifesciadvisors.com
Media: Emily Williams, Senior Director of Communications, media@satellos.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.